Screener
BioCryst Pharmaceuticals BCRX Business Segments — Interest Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income (loss) from operations | 98,465 | 29,786 | (603,133) | 51,013 |
| Other income (expense): | ||||
| Interest income | 2,434 | 2,516 | 4,690 | 5,540 |
| Interest expense | (21,712) | (21,582) | (41,491) | (45,076) |
| Foreign currency gains (losses), net | 27 | (63) | (198) | (62) |
| Loss on extinguishment of debt | — | (4,171) | — | (4,171) |
| Other income (expense), net | 260 | — | (1,202) | — |
| Total other expense, net | (18,991) | (23,300) | (38,201) | (43,769) |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's business segments — interest expense?
- BioCryst Pharmaceuticals (BCRX) reported business segments — interest expense of $21.71M in Q2 2026.
- How has BioCryst Pharmaceuticals's business segments — interest expense changed year-over-year?
- BioCryst Pharmaceuticals's business segments — interest expense increased by 0.6% year-over-year, from $21.58M to $21.71M.
- What is the long-term trend for BioCryst Pharmaceuticals's business segments — interest expense?
- Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's business segments — interest expense has grown at a -7.3% compound annual growth rate (CAGR), from $99.09M to $78.87M.
- What does business segments — interest expense mean?
- Represents the cost of borrowing funds, including interest on debt obligations and amortization of debt issuance costs. High levels of interest expense relative to revenue can indicate significant financial leverage and risk.
Ask your AI about BioCryst Pharmaceuticals's business segments — interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude